Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pilose antler extracts are bioactive preparations derived from the unossified, fast-growing antlers of deer (commonly sika deer, *Cervus nippon* Temminck), widely used in traditional Chinese medicine (TCM). They contain a complex mixture of peptides, proteins, and other biomolecules, most notably pilose antler peptide (PAP). These extracts exhibit **anti-inflammatory, antioxidant, immunomodulatory, neuroprotective, and anti-aging activities**. Reported mechanisms include modulation of several signaling pathways (such as AMPK/Sirt1/NF-κB/NLRP3, TGF-β/SMAD, AKT, and Wnt) that mediate inflammation, oxidative stress, and tissue regeneration. Primary research suggests applications in **depression, psoriasis, heart disease, and androgenetic alopecia**, but strong clinical evidence for many indications is lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pilose antler extracts.